Whetstone Capital Advisors LLC Acquires Shares of 869,275 Definitive Healthcare Corp. $DH

Key Points

• Whetstone Capital Advisors LLC has acquired 869,275 shares of Definitive Healthcare Corp., valued at approximately $2.5 million, making it the 22nd biggest holding in their portfolio.
• Definitive Healthcare's stock currently has a consensus price target of $4.73, with ratings ranging from "Buy" to "Sell" from various analysts.
• The company's current market cap is $532.48 million, and its shares have fluctuated between a low of $2.15 and a high of $5.68 in the last year.

Whetstone Capital Advisors LLC bought a new stake in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 869,275 shares of the company's stock, valued at approximately $2,512,000. Definitive Healthcare makes up about 1.1% of Whetstone Capital Advisors LLC's portfolio, making the stock its 22nd largest holding. Whetstone Capital Advisors LLC owned approximately 0.81% of Definitive Healthcare as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD boosted its stake in Definitive Healthcare by 20.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 20,572 shares of the company's stock valued at $85,000 after acquiring an additional 3,496 shares in the last quarter. Canada Pension Plan Investment Board boosted its stake in Definitive Healthcare by 18.1% in the fourth quarter. Canada Pension Plan Investment Board now owns 29,300 shares of the company's stock valued at $120,000 after acquiring an additional 4,500 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Definitive Healthcare by 6.2% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 81,358 shares of the company's stock valued at $334,000 after acquiring an additional 4,748 shares in the last quarter. ProShare Advisors LLC boosted its stake in Definitive Healthcare by 49.1% in the fourth quarter. ProShare Advisors LLC now owns 15,018 shares of the company's stock valued at $62,000 after acquiring an additional 4,943 shares in the last quarter. Finally, Wells Fargo & Company MN raised its holdings in shares of Definitive Healthcare by 27.4% in the fourth quarter. Wells Fargo & Company MN now owns 31,297 shares of the company's stock worth $129,000 after buying an additional 6,736 shares during the last quarter. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Definitive Healthcare Stock Performance

Shares of Definitive Healthcare stock traded down $0.06 during trading on Tuesday, hitting $3.94. 86,446 shares of the company's stock were exchanged, compared to its average volume of 810,575. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.65 and a current ratio of 1.65. The business has a 50-day simple moving average of $3.94 and a 200-day simple moving average of $3.52. Definitive Healthcare Corp. has a 52-week low of $2.15 and a 52-week high of $5.68. The stock has a market capitalization of $563.26 million, a price-to-earnings ratio of -1.48, a PEG ratio of 5.79 and a beta of 1.64.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. BTIG Research cut shares of Definitive Healthcare from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. The Goldman Sachs Group raised their price target on shares of Definitive Healthcare from $3.00 to $3.40 and gave the stock a "neutral" rating in a report on Monday, May 12th. Stifel Nicolaus raised their price target on shares of Definitive Healthcare from $5.00 to $6.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Wall Street Zen raised shares of Definitive Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, June 21st. Finally, Robert W. Baird set a $4.00 price target on shares of Definitive Healthcare in a report on Friday, August 8th. One research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Definitive Healthcare has a consensus rating of "Hold" and a consensus price target of $4.73.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.